Amrina Pharmacy Inc
Community/Retail Pharmacy
853 E New York Ave, Brooklyn
New York, 11203-1309
718-493-8118 718-493-9187
Amrina Pharmacy Inc is an authorized DME supplier for medicare equipments and products.
Amrina Pharmacy Inc is a Community/Retail Pharmacy in Brooklyn, New York. It is located at 853 E New York Ave, Brooklyn and it's customer support contact number is 718-493-8118. The authorized person of Amrina Pharmacy Inc is Muhammed Rahman who is Vice President/ Supervising Pharmac of the pharmacy and his contact number is 718-493-8118. Active license number of Amrina Pharmacy Inc is 033612 for Community/Retail Pharmacy in New York. Amrina Pharmacy Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Amrina Pharmacy Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Amrina Pharmacy Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Amrina Pharmacy Inc |
| Type: | Community/Retail Pharmacy |
| Location: | 853 E New York Ave, Brooklyn, New York, 11203-1309 |
| Phone: | 718-493-8118 |
| Fax: | 718-493-9187 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Muhammed Rahman |
| Position: | Vice President/ Supervising Pharmac |
| Contact Number: | 718-493-8118 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1205233095 |
| NPI Enumeration Date: | 24 Nov, 2014 |
| NPI Last Update On: | 14 Jul, 2016 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Amrina Pharmacy Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 033612 | New York | Primary | |
| Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 04198147 | Medicaid | New York | |
| 2152863 | Other | | Pk |
Medicare Enrollment:
Amrina Pharmacy Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 3870801731 | O20150928000342 | Amrina Pharmacy Inc | DME SUPPLIER - PHARMACY |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 853 E New York Ave, Brooklyn, New York |
| Zip: | 11203-1309 |
| Phone Number: | 718-493-8118 |
| Fax Number: | 718-493-9187 |
Patients can reach Amrina Pharmacy Inc at
853 E New York Ave, Brooklyn, New York or can
call on customer care at 718-493-8118.
Comments/ Reviews:
Read all the reviews posted for Amrina Pharmacy Inc below. You may also share your own experience with Amrina Pharmacy Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.